Cargando…
Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
Autores principales: | Longoria, Teresa C., Eskander, Ramez N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881200/ https://www.ncbi.nlm.nih.gov/pubmed/27232495 http://dx.doi.org/10.1186/s40661-016-0021-x |
Ejemplares similares
-
Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015) -
Immunotherapy as a treatment strategy in advanced stage and recurrent
endometrial cancer: review of current phase III immunotherapy clinical
trials
por: Eskander, Ramez N., et al.
Publicado: (2021) -
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
por: Kamat, Ashish M., et al.
Publicado: (2017) -
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report
por: Paraghamian, Sarah E., et al.
Publicado: (2017) -
Erratum: Isolated humeral recurrence in endometrial carcinoma
Publicado: (2016)